Logo
x

Search

Subscribe Now

receive

Pfizer and BioNTech's COVID-19 Vaccine Receive the US FDA's Advisory Committee Vote Supporting EUA Against COVID-19

Pfizer and BioNTech's COVID-19 Vaccine Receive the US FDA's Advisory Committee Vote Supporting EUA Against COVID-19

  • October 27, 2021
Regeneron and Sanofi's Dupixent (dupilumab) Receive the US FDA's Approval as an Add-On Maintenance Treatment to Treat Moderate-To-Severe Asthma

Regeneron and Sanofi's Dupixent (dupilumab) Receive the US FDA's Approval as an Add-On Maintenance Treatment to Treat Moderate-To-...

  • October 21, 2021
BMS and bluebird bio's Abecma (idecabtagene vicleucel) Receive the US FDA's Approval as the First Anti-BCMA CAR T Cell Therapy for R/R Multiple Myeloma

BMS and bluebird bio's Abecma (idecabtagene vicleucel) Receive the US FDA's Approval as the First Anti-BCMA CAR T Cell Therapy for...

  • March 29, 2021
Regeneron and Sanofi Report the US FDA's Acceptance of sBLA for Review of Dupixent to Treat Moderate-to-Severe Asthma in Children

Regeneron and Sanofi Report the US FDA's Acceptance of sBLA for Review of Dupixent to Treat Moderate-to-Severe Asthma in Children

  • March 4, 2021
AstraZeneca and Serum Institute of India's COVID-19 Vaccine Receive WHO's EUA to Prevent COVID-19

AstraZeneca and Serum Institute of India's COVID-19 Vaccine Receive WHO's EUA to Prevent COVID-19

  • February 16, 2021
Biocon Biologics and Viatris Receive EC's Approval for Kixelle (biosimilar- insulin aspart) for Diabetes Mellitus

Biocon Biologics and Viatris Receive EC's Approval for Kixelle (biosimilar- insulin aspart) for Diabetes Mellitus

  • February 15, 2021
Dermavant’s Vtama (tapinarof) Receives the US FDA’s Approval for the Treatment of Plaque Psoriasis in Adults

    Dermavant’s Vtama (tapinarof) Receives the US FDA’s Approval for the Treatment of Plaque Psoriasis in Adults

    • May 24, 2022
    Siga’s Tpoxx (tecovirimat) Receives the US FDA’s Approval for the Treatment of Small Pox

      Siga’s Tpoxx (tecovirimat) Receives the US FDA’s Approval for the Treatment of Small Pox

      • May 19, 2022
      Mitsubishi Tanabe Pharma America’s Radicava ORS (edaravone) Receives the US FDA’s Approval for the Treatment of ALS

        Mitsubishi Tanabe Pharma America’s Radicava ORS (edaravone) Receives the US FDA’s Approval for the Treatment of ALS

        • May 13, 2022
        On Target Laboratories’s Cytalux (pafolacianine) Receives US FDA’s Approval for the Treatment of Ovarian Cancer

          On Target Laboratories’s Cytalux (pafolacianine) Receives US FDA’s Approval for the Treatment of Ovarian Cancer

          • November 29, 2021
          Pfizer and BioNTech

            Pfizer and BioNTech's COVID-19 Vaccine Receive the US FDA's Advisory Committee Vote Supporting EUA Against COVID-19

            • October 27, 2021
            Genentech

              Genentech's Susvimo Receives the US FDA's Approval for the Treatment of Wet Age-Related Macular Degeneration

              • October 25, 2021
              Image

              Incisive News in 3 Shots.

              Contact Us

              Our Information

              Follow Us

              Copyright © 2025 PharmaShots - All Rights Reserved.